Brief: Edgewise Therapeutics Q1 Operating Expenses USD 45.959 Million
08/05/2025 13:00
May 08 (Reuters) - Edgewise Therapeutics Q1 basic EPS USD -0.43. Q1 net income USD -40.798 million Q1 operating income USD -45.959 million
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending